Refine
Has Fulltext
- yes (53)
Year of publication
Document Type
- Journal article (53)
Language
- English (53)
Keywords
- consortium (4)
- genetic modifiers (3)
- investigators (3)
- Escherichia coli (2)
- Staphylococcus aureus (2)
- breast cancer (2)
- common variants (2)
- genome-wide association (2)
- global change (2)
- infection (2)
- modifiers (2)
- ovarian cancer (2)
- single-nucleotide polymorphisms (2)
- survival (2)
- susceptibility loci (2)
- 3D-conformal radiotherapy (1)
- ADHD (1)
- AIDS (1)
- ALS treatment (1)
- ARDS (acute respiratory distress syndrome) (1)
- ARIA (1)
- Amyotrophic Lateral Sclerosis (ALS) (1)
- Amyotrophic Lateral Sclerosis Assessment Questionnaire 5 (ALSAQ-5) (1)
- BDNF (1)
- BRCA1/2 (1)
- Bembix (1)
- Blood-brain barrier (1)
- Bombus Spp. Hymenoptera (1)
- Breast-tumors (1)
- CADe (1)
- CAR T-cell (1)
- CARAT (1)
- CDC14A (1)
- COVID-19 (1)
- CT angiography (1)
- CT perfusion (1)
- Chrysididae (1)
- DFNB32 (1)
- DNA (1)
- DNA damage (1)
- DNA storage (1)
- DOTATOC (1)
- DRD1 (1)
- EVT (1)
- EuroQol Five Dimension Five Level Scale (EQ-5D-5L) (1)
- F-19 MRI (1)
- GPCR (1)
- Gene-expression (1)
- Genotype–phenotype correlations (1)
- Germany (1)
- Histologic grade (1)
- Images (1)
- In-vivo (1)
- Inflammation (1)
- Iron-oxide (1)
- Iron-uptake (1)
- Langerhans cells (1)
- Lesions (1)
- MASK (1)
- MRI reporter (1)
- MTH1 (1)
- Male breast cancer (1)
- Mexican coffee plantations (1)
- Mice (1)
- NEIL2 (1)
- NIHSS (1)
- Northeastern Costa Rica (1)
- OGG1 (1)
- Ovarian (1)
- PET (1)
- Particles (1)
- Pathology (1)
- Proteins (1)
- RCT (1)
- Rats (1)
- SSTR (1)
- Salmonella-typhimurium (1)
- Scheimpflug (1)
- Soft-tissue infection (1)
- Sugar-transport (1)
- T cells (1)
- TH1579 (1)
- TH588 (1)
- TIC disorders (1)
- Therapy (1)
- Tracking (1)
- TrkB (1)
- Usher syndrome (1)
- ZNF365 (1)
- [18F]FDG-PET-CT (1)
- \(\alpha\)-phase (1)
- \(\beta\)-phase (1)
- abdominal lymph node metastases (1)
- abscisic acid (ABA) (1)
- acquired immunodeficiency-syndrome (1)
- adolescents (1)
- adverse drug reaction (1)
- aggregation (1)
- alleles (1)
- amyotrophic lateral sclerosis (ALS) (1)
- androgen deprivation therapy (1)
- antibiotic resistance (1)
- anticoagulation (1)
- antimicrobials (1)
- anxiety (1)
- artifacts (1)
- artificial intelligence (1)
- assay systems (1)
- assistive devices (1)
- asthma (1)
- atrial fibrillation (1)
- attention-deficit/hyperactivity disorder (1)
- attention-deficit/hyperactivity disorder (ADHD) (1)
- attention‐deficit (1)
- autism (1)
- autosomal recessive hearing loss (1)
- bacterial cellulose dressing (1)
- basal ganglia (1)
- bead models (1)
- behaviour therapy (1)
- binding analysis (1)
- biological models (1)
- biology (1)
- biopharmaceuticals (1)
- bipolar disorder (1)
- bird species richness (1)
- brain (1)
- brain asymmetry (1)
- brain laterality (1)
- bridging (1)
- bumblebee nest density (1)
- c-Myc (1)
- calcium (1)
- cancer (1)
- cancer genomics (1)
- cardiac morbidity (1)
- cardiac mortality (1)
- caregiver burden (1)
- carrier transport (1)
- cell (1)
- cell death (1)
- cell differentiation (1)
- cell staining (1)
- charge transport (1)
- chemical mimicry (1)
- children (1)
- chip-seq (1)
- cohort study (1)
- coleoptera (1)
- colonoscopy (1)
- combined retinal dystrophy (1)
- common SNPS (1)
- complex diseases (1)
- coprophagous beetles (1)
- corneal confocal microscopy (1)
- cortico-striatal synapse (1)
- cuticular hydrocarbons (1)
- dSPN (1)
- damage (1)
- data mining (1)
- data quality (1)
- data sharing (1)
- decomposition (1)
- decreasing autonomy (1)
- deep learning (1)
- depression (1)
- digital transformation of health and care (1)
- direct pathway (1)
- disturbance extent (1)
- disturbance severity (1)
- diversity–disturbance relationship (1)
- dung beetle coleoptera (1)
- electroencephalography (EEG) (1)
- elements (1)
- exome sequencing (1)
- expression (1)
- expression signature (1)
- eyes (1)
- family (1)
- fibromyalgia syndrome (1)
- field flow fractionation (1)
- flg22 (1)
- fluorescence-detected sedimentation (1)
- forest communities (1)
- foxes vulpes-vulpes (1)
- frameshift (1)
- functional status (1)
- genetic interaction networks (1)
- genetic variants (1)
- genotype-phenotype patterns (1)
- gilles (1)
- glycolipids (1)
- guard cells (1)
- guidelines & recommendations (1)
- habitat destruction (1)
- haplogroups (1)
- haze (1)
- health-related quality of life (1)
- health-related quality of life (HRQoL) (1)
- hearing impairment (1)
- helminths (1)
- hemolytic anemia (1)
- high-throughput screening (1)
- hill numbers (1)
- hormone-related protein (1)
- hydrodynamics (1)
- hyperactivity disorder (1)
- imaging (1)
- immune check inhibitor (1)
- in vivo experiments (1)
- inappropriate medication (1)
- individualised modular treatment programme (1)
- induced phase transition (1)
- infectious diseases (1)
- informal caregiving (1)
- instensively managed farmland (1)
- intensive care medicine (1)
- intermediate disturbance hypothesis (1)
- invasive cysticerocsis (1)
- ion signaling (1)
- land use (1)
- land-use change (1)
- large vessel occlusion (1)
- large‐scale data (1)
- light-gated proteins (1)
- lipids (1)
- low-molecular heparin (1)
- lymph node metastases (1)
- major histocompatibility complex (1)
- mammographic density (1)
- materials design (1)
- metastasis-directed therapy (1)
- microbiome (1)
- minimum reporting standards (1)
- missing heritability (1)
- mobility (1)
- moisture balance (1)
- molecular diagnostics (1)
- molecular imaging (1)
- motor learning (1)
- multicenter study (1)
- multiparametric CT (1)
- multiple diseases (1)
- multiresistance (1)
- nanocellulose (1)
- natural disturbance (1)
- neonates (1)
- network analysis (1)
- neuropsychiatric disorders (1)
- non-sense mediated mRNA decay (1)
- nursing home residents (1)
- oligmometastases (1)
- oligomers (1)
- oligorecurrence (1)
- oncogenesis (1)
- oncolysis (1)
- organic semiconductors (1)
- oxidative stress (1)
- pH (1)
- paediatric cancer (1)
- pain (1)
- pandemia (1)
- parathyroid carcinoma (1)
- pathogenic bacteria (1)
- patient (1)
- pembrolizumab (1)
- pentacene (1)
- persistence (1)
- plant community composition (1)
- pollen tube (1)
- polymorphism (1)
- polyp (1)
- polypharmacy (1)
- population (1)
- postoperative bleeding (1)
- predictive markers (1)
- prescribing omission (1)
- prolonged cytopenia (1)
- prostate cancer (1)
- protein chip (1)
- proteins (1)
- psychological support (1)
- quality of life (QoL) (1)
- radiation therapy (1)
- repeated surgery (1)
- replication stress (1)
- reporter gene (1)
- rhinitis (1)
- riboflavin (1)
- rule discovery (1)
- sarcoidosis (1)
- secondary wound dressing (1)
- selection (1)
- single-electron transistors (1)
- size exclusion chromatography (1)
- small fiber neuropathy (1)
- socioeconomic status (1)
- software (1)
- somatostatin receptor (1)
- spinco ultracentrifuge (1)
- splicing (1)
- stereotactic body radiotherapy (1)
- stroke (1)
- structural MRI (1)
- subphenotypes (1)
- subtypes (1)
- surfactants (1)
- susceptibility (1)
- susceptibility alleles (1)
- symptom-specific treatment (1)
- synaptic plasticity (1)
- telephone-assisted self-help (1)
- thin-film transistors (1)
- thromboembolism (1)
- transcutaneous auricular vagus nerve stimulation (1)
- transcutaneous cervical vagus nerve stimulation (1)
- transcutaneous vagus nerve stimulation (1)
- translational research (1)
- transmission (1)
- tumor subtypes (1)
- ultraviolet-a (1)
- urban-rural gradient (1)
- variants (1)
- velocity (1)
- virotherapy (1)
- wound healing (1)
- α‐diversity (1)
- β‐diversity (1)
- “bulbar-onset” ALS (bALS) (1)
- “limb-onset” ALS (lALS) (1)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (13)
- Institut für Humangenetik (8)
- Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (4)
- Medizinische Klinik und Poliklinik I (4)
- Medizinische Klinik und Poliklinik II (4)
- Neurologische Klinik und Poliklinik (4)
- Physikalisches Institut (4)
- Institut für Molekulare Infektionsbiologie (3)
- Pathologisches Institut (3)
- Rudolf-Virchow-Zentrum (3)
Sonstige beteiligte Institutionen
CD1d molecules are MHC class I-like molecules that present glycolipids to iNKT cells. The highly conserved interaction between CD1d:α-Galactosylceramide (αGC) complexes and the iNKT TCR not only defines this population of αβ T cells but can also be used for its direct identification. Therefore, CD1d oligomers are a widely used tool for iNKT cell related investigations. To this end, the lipid chains of the antigen have to be inserted into the hydrophobic pockets of the CD1d binding cleft, often with help of surfactants. In this study, we investigated the influence of different surfactants (Triton X-100, Tween 20, Tyloxapol) on in vitro loading of CD1d molecules derived from four different species (human, mouse, rat and cotton rat) with αGC and derivatives carrying modifications of the acyl-chain (DB01-1, PBS44) and a 6-acetamido-6-deoxy-addition at the galactosyl head group (PBS57). We also compared rat CD1d dimers with tetramers and staining of an iNKT TCR transductant was used as readout for loading efficacy. The results underlined the importance of CD1d loading efficacy for proper analysis of iNKT TCR binding and demonstrated the necessity to adjust loading conditions for each oligomer/glycolipid combination. The efficient usage of surfactants as a tool for CD1d loading was revealed to be species-specific and depending on the origin of the CD1d producing cells. Additional variation of surfactant-dependent loading efficacy between tested glycolipids was influenced by the acyl-chain length and the modification of the galactosyl head group with PBS57 showing the least dependence on surfactants and the lowest degree of species-dependent differences.
We reported earlier the diagnostic potential of a melanogenic vaccinia virus based system in magnetic resonance (MRI) and optoacoustic deep tissue imaging (MSOT). Since melanin overproduction lead to attenuated virus replication, we constructed a novel recombinant vaccinia virus strain (rVACV), GLV-1h462, which expressed the key enzyme of melanogenesis (tyrosinase) under the control of an inducible promoter-system. In this study melanin production was detected after exogenous addition of doxycycline in two different tumor xenograft mouse models. Furthermore, it was confirmed that this novel vaccinia virus strain still facilitated signal enhancement as detected by MRI and optoacoustic tomography. At the same time we demonstrated an enhanced oncolytic potential compared to the constitutively melanin synthesizing rVACV system.
Introduction: Several common alleles have been shown to be associated with breast and/or ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. Recent genome-wide association studies of breast cancer have identified eight additional breast cancer susceptibility loci: rs1011970 (9p21, CDKN2A/B), rs10995190 (ZNF365), rs704010 (ZMIZ1), rs2380205 (10p15), rs614367 (11q13), rs1292011 (12q24), rs10771399 (12p11 near PTHLH) and rs865686 (9q31.2).
Methods: To evaluate whether these single nucleotide polymorphisms (SNPs) are associated with breast cancer risk for BRCA1 and BRCA2 carriers, we genotyped these SNPs in 12,599 BRCA1 and 7,132 BRCA2 mutation carriers and analysed the associations with breast cancer risk within a retrospective likelihood framework.
Results: Only SNP rs10771399 near PTHLH was associated with breast cancer risk for BRCA1 mutation carriers (per-allele hazard ratio (HR) = 0.87, 95% CI: 0.81 to 0.94, P-trend = 3 x 10\(^{-4}\)). The association was restricted to mutations proven or predicted to lead to absence of protein expression (HR = 0.82, 95% CI: 0.74 to 0.90, P-trend = 3.1 x 10\(^{-5}\), P-difference = 0.03). Four SNPs were associated with the risk of breast cancer for BRCA2 mutation carriers: rs10995190, P-trend = 0.015; rs1011970, P-trend = 0.048; rs865686, 2df P = 0.007; rs1292011 2df P = 0.03. rs10771399 (PTHLH) was predominantly associated with estrogen receptor (ER)-negative breast cancer for BRCA1 mutation carriers (HR = 0.81, 95% CI: 0.74 to 0.90, P-trend = 4 x 10\(^{-5}\)) and there was marginal evidence of association with ER- negative breast cancer for BRCA2 mutation carriers (HR = 0.78, 95% CI: 0.62 to 1.00, P-trend = 0.049).
Conclusions: The present findings, in combination with previously identified modifiers of risk, will ultimately lead to more accurate risk prediction and an improved understanding of the disease etiology in BRCA1 and BRCA2 mutation carriers.
Human cysticercosis caused by Taenia crassiceps tapeworm larvae involves the muscles and subcutis mostly in immunocompromised patients and the eye in immunocompetent persons. We report a successfully treated cerebellar infection in an immunocompetent woman. We developed serologic tests, and the parasite was identified by histologic examination and 12s rDNA PCR and sequencing.
Usher syndrome, the most prevalent cause of combined hereditary vision and hearing impairment, is clinically and genetically heterogeneous. Moreover, several conditions with phenotypes overlapping Usher syndrome have been described. This makes the molecular diagnosis of hereditary deaf-blindness challenging. Here, we performed exome sequencing and analysis on 7 Mexican and 52 Iranian probands with combined retinal degeneration and hearing impairment (without intellectual disability). Clinical assessment involved ophthalmological examination and hearing loss questionnaire. Usher syndrome, most frequently due to biallelic variants in MYO7A (USH1B in 16 probands), USH2A (17 probands), and ADGRV1 (USH2C in 7 probands), was diagnosed in 44 of 59 (75%) unrelated probands. Almost half of the identified variants were novel. Nine of 59 (15%) probands displayed other genetic entities with dual sensory impairment, including Alström syndrome (3 patients), cone-rod dystrophy and hearing loss 1 (2 probands), and Heimler syndrome (1 patient). Unexpected findings included one proband each with Scheie syndrome, coenzyme Q10 deficiency, and pseudoxanthoma elasticum. In four probands, including three Usher cases, dual sensory impairment was either modified/aggravated or caused by variants in distinct genes associated with retinal degeneration and/or hearing loss. The overall diagnostic yield of whole exome analysis in our deaf-blind cohort was 92%. Two (3%) probands were partially solved and only 3 (5%) remained without any molecular diagnosis. In many cases, the molecular diagnosis is important to guide genetic counseling, to support prognostic outcomes and decisions with currently available and evolving treatment modalities.
Parathyroid carcinoma (PC) is an orphan malignancy accounting for only ~1% of all cases with primary hyperparathyroidism. The localization of recurrent PC is of critical importance and can be exceedingly difficult to diagnose and sometimes futile when common sites of recurrence in the neck and chest cannot be confirmed. Here, we present the diagnostic workup, molecular analysis and multimodal therapy of a 46-year old woman with the extraordinary manifestation of abdominal lymph node metastases 12 years after primary diagnosis of PC. The patient was referred to our endocrine tumor center in 2016 with the aim to localize the tumor causative of symptomatic biochemical recurrence. In view of the extensive previous workup we decided to perform [18F]FDG-PET-CT. A pathological lymph node in the liver hilus showed slightly increased FDG-uptake and hence was suspected as site of recurrence. Selective venous sampling confirmed increased parathyroid hormone concentration in liver veins. Abdominal lymph node metastasis was resected and histopathological examination confirmed PC. Within four months, the patient experienced biochemical recurrence and based on high tumor mutational burden detected in the surgical specimen by whole exome sequencing the patient received immunotherapy with pembrolizumab that led to a biochemical response. Subsequent to disease progression repeated abdominal lymph node resection was performed in 10/2018, 01/2019 and in 01/2020. Up to now (12/2020) the patient is biochemically free of disease. In conclusion, a multimodal diagnostic approach and therapy in an interdisciplinary setting is needed for patients with rare endocrine tumors. Molecular analyses may inform additional treatment options including checkpoint inhibitors such as pembrolizumab.
CDC14A encodes the Cell Division Cycle 14A protein and has been associated with autosomal recessive non-syndromic hearing loss (DFNB32), as well as hearing impairment and infertile male syndrome (HIIMS) since 2016. To date, only nine variants have been associated in patients whose initial symptoms included moderate-to-profound hearing impairment. Exome analysis of Iranian and Pakistani probands who both showed bilateral, sensorineural hearing loss revealed a novel splice site variant (c.1421+2T>C, p.?) that disrupts the splice donor site and a novel frameshift variant (c.1041dup, p.Ser348Glnfs*2) in the gene CDC14A, respectively. To evaluate the pathogenicity of both loss-of-function variants, we analyzed the effects of both variants on the RNA-level. The splice variant was characterized using a minigene assay. Altered expression levels due to the c.1041dup variant were assessed using RT-qPCR. In summary, cDNA analysis confirmed that the c.1421+2T>C variant activates a cryptic splice site, resulting in a truncated transcript (c.1414_1421del, p.Val472Leufs*20) and the c.1041dup variant results in a defective transcript that is likely degraded by nonsense-mediated mRNA decay. The present study functionally characterizes two variants and provides further confirmatory evidence that CDC14A is associated with a rare form of hereditary hearing loss.
Physical properties of active materials built up from small molecules are dictated by their molecular packing in the solid state. Here we demonstrate for the first time the growth of n-channel single-crystal field-effect transistors and organic thin-film transistors by sublimation of 2,6-dichloro-naphthalene diimide in air. Under these conditions, a new polymorph with two-dimensional brick-wall packing mode (\(\beta\)-phase) is obtained that is distinguished from the previously reported herringbone packing motif obtained from solution (\(\alpha\)-phase). We are able to fabricate single-crystal field-effect transistors with electron mobilities in air of up to 8.6 cm\(^{2}\)V\(^{-1}\)s\(^{-1}\) (\(\alpha\)-phase) and up to 3.5 cm\(^{2}\)V\(^{-1}\)s\(^{-1}\) (\(\beta\)-phase) on n-octadecyltriethoxysilane-modified substrates. On silicon dioxide, thin-film devices based on \(\beta\)-phase can be manufactured in air giving rise to electron mobilities of 0.37 cm\(^{2}\)V\(^{-1}\)s\(^{-1}\). The simple crystal and thin-film growth procedures by sublimation under ambient conditions avoid elaborate substrate modifications and costly vacuum equipment-based fabrication steps.
Background
BRCA1 and, more commonly, BRCA2 mutations are associated with increased risk of male breast cancer (MBC). However, only a paucity of data exists on the pathology of breast cancers (BCs) in men with BRCA1/2 mutations. Using the largest available dataset, we determined whether MBCs arising in BRCA1/2 mutation carriers display specific pathologic features and whether these features differ from those of BRCA1/2 female BCs (FBCs).
Methods
We characterised the pathologic features of 419 BRCA1/2 MBCs and, using logistic regression analysis, contrasted those with data from 9675 BRCA1/2 FBCs and with population-based data from 6351 MBCs in the Surveillance, Epidemiology, and End Results (SEER) database.
Results
Among BRCA2 MBCs, grade significantly decreased with increasing age at diagnosis (P = 0.005). Compared with BRCA2 FBCs, BRCA2 MBCs were of significantly higher stage (P for trend = 2 × 10−5) and higher grade (P for trend = 0.005) and were more likely to be oestrogen receptor–positive [odds ratio (OR) 10.59; 95 % confidence interval (CI) 5.15–21.80] and progesterone receptor–positive (OR 5.04; 95 % CI 3.17–8.04). With the exception of grade, similar patterns of associations emerged when we compared BRCA1 MBCs and FBCs. BRCA2 MBCs also presented with higher grade than MBCs from the SEER database (P for trend = 4 × 10−12).
Conclusions
On the basis of the largest series analysed to date, our results show that BRCA1/2 MBCs display distinct pathologic characteristics compared with BRCA1/2 FBCs, and we identified a specific BRCA2-associated MBC phenotype characterised by a variable suggesting greater biological aggressiveness (i.e., high histologic grade). These findings could lead to the development of gender-specific risk prediction models and guide clinical strategies appropriate for MBC management.
The rapid development of green and sustainable materials opens up new possibilities in the field of applied research. Such materials include nanocellulose composites that can integrate many components into composites and provide a good chassis for smart devices. In our study, we evaluate four approaches for turning a nanocellulose composite into an information storage or processing device: 1) nanocellulose can be a suitable carrier material and protect information stored in DNA. 2) Nucleotide-processing enzymes (polymerase and exonuclease) can be controlled by light after fusing them with light-gating domains; nucleotide substrate specificity can be changed by mutation or pH change (read-in and read-out of the information). 3) Semiconductors and electronic capabilities can be achieved: we show that nanocellulose is rendered electronic by iodine treatment replacing silicon including microstructures. Nanocellulose semiconductor properties are measured, and the resulting potential including single-electron transistors (SET) and their properties are modeled. Electric current can also be transported by DNA through G-quadruplex DNA molecules; these as well as classical silicon semiconductors can easily be integrated into the nanocellulose composite. 4) To elaborate upon miniaturization and integration for a smart nanocellulose chip device, we demonstrate pH-sensitive dyes in nanocellulose, nanopore creation, and kinase micropatterning on bacterial membranes as well as digital PCR micro-wells. Future application potential includes nano-3D printing and fast molecular processors (e.g., SETs) integrated with DNA storage and conventional electronics. This would also lead to environment-friendly nanocellulose chips for information processing as well as smart nanocellulose composites for biomedical applications and nano-factories.